EUVIMEDEUVIMED entdecken
Crossref

Does Anterior Commissure Involvement Matter for Early‐Stage Glottic Cancer in the Intensity‐Modulated Radiotherapy Era?

Alper Kahvecioglu iD, Gozde Yazici, Sepideh Mohammadipour, Melek Tugce Yilmaz iD, Sezin Yuce Sari, Gokhan Ozyigit, Mustafa Cengiz

Head & Neck · 2025

DOI: 10.1002/hed.28216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Alper Kahvecioglu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Laryngeal Neoplasms, Glottis. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Anterior commissure involvement (ACI) is a negative prognostic factor for local control (LC) in early‐stage glottic cancer (ESGC) treated with radiotherapy (RT). However, its impact in the intensity‐modulated radiotherapy (IMRT) era remains unclear. This study evaluated the prognostic significance of ACI and its relationship with the RT technique. Materials and Methods Records of 154 ESGC patients treated with definitive RT between 2000 and 2024 were retrospectively analyzed. Conventional techniques including two‐dimensional radiotherapy (2DRT) and three‐dimensional conformal radiotherapy (3DCRT) were used in 67% of patients ( n = 103), while 33% ( n = 51) underwent IMRT. ACI was present in 41% of patients treated with 2DRT/3DCRT and 31% of those treated with IMRT.

Results

The cohort included 8% TisN0M0, 60% T1N0M0, and 32% T2N0M0 cases, with a median follow‐up of 87 months. The 2‐ and 5‐year local recurrence‐free survival (LRFS) rate was 91% and 80%, respectively. The presence of ACI was associated with a significantly lower 5‐year LRFS rate in patients treated with 2DRT/3DCRT (71% vs. 90%, p = 0.03), whereas no significant difference was observed among those treated with IMRT (81% vs. 77%, p = 0.13).

Conclusion

Although ACI is associated with a poorer LRFS in ESGC patients receiving RT, our findings indicate that the use of IMRT may help alleviate this adverse effect to some extent. These observations warrant further investigation but may have implications for optimizing treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedLaryngeal NeoplasmsGlottisHumansMaleFemaleRetrospective StudiesMiddle AgedAgedNeoplasm StagingAdultAged, 80 and overPrognosisDisease-Free SurvivalRadiotherapy, ConformalNeoplasm Recurrence, LocalTreatment Outcome

Stichwörter der Autor:innen

anterior commissure involvementglottic laryngeal cancerintensity‐modulated radiotherapylocal controlradiotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

ORCID-Profile: Alper Kahvecioglu, Melek Tugce Yilmaz

Zitieren

APA

Kahvecioglu, A., Yazici, G., Mohammadipour, S., Yilmaz, M. T., Sari, S. Y., Ozyigit, G., & Cengiz, M. (2025). Does Anterior Commissure Involvement Matter for Early‐Stage Glottic Cancer in the Intensity‐Modulated Radiotherapy Era?. Head & Neck. https://doi.org/10.1002/hed.28216

Vancouver

Kahvecioglu A, Yazici G, Mohammadipour S, Yilmaz MT, Sari SY, Ozyigit G, et al. Does Anterior Commissure Involvement Matter for Early‐Stage Glottic Cancer in the Intensity‐Modulated Radiotherapy Era?. Head & Neck. 2025. doi:10.1002/hed.28216

BibTeX
@article{Kahvecioglu2025,
  author = {Kahvecioglu, Alper and Yazici, Gozde and Mohammadipour, Sepideh and Yilmaz, Melek Tugce and Sari, Sezin Yuce and Ozyigit, Gokhan and Cengiz, Mustafa},
  title = {Does Anterior Commissure Involvement Matter for Early‐Stage Glottic Cancer in the Intensity‐Modulated Radiotherapy Era?},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28216}
}
Kostenlos starten →